bio-reference labs inc (BRLI:NASDAQ GS)

Financial Statements for bio-reference labs inc (BRLI)

Currency in Millions of US Dollars	As of:	Oct 31 2009	Oct 31 2010	Oct 31 2011	Oct 31 2012	4 Year Trend
Revenues		362.7	458.0	558.6	661.7
TOTAL REVENUES		362.7	458.0	558.6	661.7
Cost of Goods Sold		176.3	223.6	276.8	324.5
GROSS PROFIT		186.4	234.4	281.8	337.1
Selling General & Admin Expenses, Total		138.3	174.2	207.0	244.3
Depreciation & Amortization, Total		9.8	11.8	15.0	16.7
OTHER OPERATING EXPENSES, TOTAL		148.1	186.0	222.1	261.0
OPERATING INCOME		38.3	48.4	59.8	76.1
Interest Expense		-1.5	-1.6	-1.7	-1.5
Interest and Investment Income		0.2	0.2	0.2	0.2
Other Non-Operating Expenses, Total		--	--	6.7	-0.3
Other Non-Operating Income (Expenses)		--	--	6.7	--
Other Unusual Items, Total		1.6	--	--	--
EBT, INCLUDING UNUSUAL ITEMS		38.6	47.0	64.8	74.5
Income Tax Expense		16.7	20.6	28.5	32.4
Earnings from Continuing Operations		21.9	26.4	36.4	42.2
NET INCOME		21.9	26.4	36.4	42.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		21.9	26.4	36.4	42.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		21.9	26.4	36.4	42.2

Report Data Issue

To contact BIO-REFERENCE LABS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.